AlQabas: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
Times: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
AlWasat: DDI wins the UN Interagency Task Force on prevention of NCD’s, prestigious award for its efforts in addressing diabetes and its complications
Scientists at DDI discover a new Branch in the regulation of IL-6 in Fat cells
Kuwait is amongst top-ranking nations afflicted badly by obesity epidemic and its wide-scale complications such as increased blood pressure, heart disease, stroke, digestive problems, certain cancers
Meet the Scientist – Maha Hammad
MAHA HAMMAD graduated from Kuwait University with a BSc in Biochemistry and Molecular Biology (Distinction with Class Honours). She pursued her graduate studies in Canada.
Scientists at DDI discover a mutation in the kuwaiti population that causes obesity
The Leptin-Melanocortin pathway is an important system in the regulation of food intake and energy expenditure. It is unique because it can integrate neural, metabolic, and hormonal signals. One k
DDI wins the UN Interagency Task Force on prevention of NCD’s
This is a prestigious award given to DDI its efforts in addressing diabetes and its complications After careful consideration by the UN Interagency Task Force on prevention of noncommunicable
DDI was granted fourth patent for 2021
DDI’s researchers were granted the 4th patent of 2021 by the U.S. Patent & Trademark Office for our new invention on “Methods of Inhibiting MMP-9” by our DDI Inventors from the department o
DDI granted 3rd patent right!
The Biochemistry and Molecular Biology researchers were granted the U.S. patent rights on our new invention “MicroRNA ANGPTL3 INHIBITOR” on 13th July 2021. The patent was ultimately issued from the U
DDI’s researchers on #1 show in Kuwait
DDI’s researchers were invited to the #1 show on KTV1 ‘Layali AlKuwait’ to discuss the latest research achievements and findings. Dr. Faisal Al-Refaei, Chief Operating Officer, Dr.
Biochemistry and Molecular Biology Unit are granted a patent
The DDI “Patent and Research Translation Committee” congratulates the researchers on the grant of U.S. patent on our new invention “Use of MicroRNA-103 as Inhibitor for dyslipidemia by repressin
Exploring the Link Between Genes, Diabetes and COVID-19 Outcomes
Prof. Fahd Almulla and his colleagues investigate what makes some cases of COVID-19 more severe. A striking feature of COVID-19 has been the variability in outcome, which ranges from silent infect
Meet the Scientist – Amal Hasan
AMAL HASSAN Meet the scientists behind DDI’s research AMAL HASAN graduated in Zoology from Kuwait University; and studied for an MSc in Immunology and Allergy and a PhD in Immunology, at th
Elevated resting heart as a predictor of cardiovascular risk in Healthy Obese individuals
The autonomic nervous system is a control system that governs body activities such as digestion, respiratory rate, pupillary response, and heart rate in a mostly unconscious manner. This system i
DDI Genomics team prove that SARS-COV-2 virus has been recombining as early as March 2020
Genomics and Bioinformatics Department members were able to prove that different strains or variants of SARS-CoV-2 coronavirus are co-infecting and combining their genomes in one patient. This means
IRAP, A novel biomarker of prediabetes and Type 2 diabetes?
Type 2 diabetes is increasing worldwide, causing both a health and socioeconomic burden. Fortunately, type 2 diabetes can be prevented if proper intervention is introduced during the early stages of
AlQabas-Two COVID-19 strains can merge into a more contagious strain
Times-DDI’s researchers urge policy makers to speed up vaccine process
Alanbaa-Speed up COVID-19 vaccination to prevent from a deadlier COVID-19 strain
DDI joins a research study that explains why COVID-19 effects young adults